Assuming we don't get approval to uplist which I think we can assume at these prices, what is our best case scenerio from there? Just hope that tax credit gets utilized? How on earth does it take this long to use a tax credit? I guess it's complicated since we've been paying someone to figure it out. How do we turn around on the OTC? Does anyone see a way we can possibly uplist here? We are close to the Nasdaq delisting price. Just can't see it happening
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links